Loading…
Endo International's subsidiary Par Sterile Products entered a cooperative agreement with the U.S. government to expand its sterile fill-finish manufacturing capacity at its Rochester, Michigan plant. The U.S. government will fund approximately $90 million of the total expected cost of approximately $120 million.
“the U.S. government will fund approximately $90 million of the program's total expected cost of approximately $120 million.”investor.endo.com
Summarized from public sources; check the original articles before acting on it.